Jinyu Bio-technology Co., Ltd.

600201

CNE000000Y37

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
9.11 ^CNY	-0.87%		+3.05%	-15.41%

Feb. 27	Taihe Technologies' Chief Financial Officer Resigns	MT
2023	Jinyu Bio-Technology's Unit Ties Up With Shanghai Lanque Biomedicine for African Swine Fever Vaccine Development	MT

Jinyu Bio-technology Co., Ltd.(SHSE:600201) dropped from Shanghai Stock Exchange Health Care Sector Index

December 10, 2021 at 12:00 am EST

Jinyu Bio-technology Co., Ltd. has been removed from Shanghai Stock Exchange Health Care Sector Index.

Latest news about Jinyu Bio-technology Co., Ltd.

Taihe Technologies' Chief Financial Officer Resigns	Feb. 27	MT
Jinyu Bio-Technology's Unit Ties Up With Shanghai Lanque Biomedicine for African Swine Fever Vaccine Development	Dec. 12	MT
Jinyu Bio-Technology Teams Up with RNA Cure to Develop mRNA Vaccine for African Swine Fever	Dec. 11	MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Jinyu Bio-Technology's Unit Cattle Vaccine Passes Emergency Evaluation in China	23-10-25	MT
Jinyu Bio-Technology Wins Nod to Market Veterinary Vaccine	23-09-29	MT
Jinyu Bio-technology Co., Ltd.(XSSC:600201) added to S&P Global BMI Index	23-09-18	CI
Jinyu Bio-technology Co., Ltd.(XSSC:600201) added to FTSE All-World Index	23-09-18	CI
Jinyu Bio-Technology Registers Veterinary Vaccine For Sheep	23-09-06	MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Jinyu Bio-Technology Selling 800 Million Yuan Shares to Expand Animal Vaccine Production	23-05-10	MT
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.	23-04-03	CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.	23-04-03	CI
Jinyu Bio-technology Co., Ltd.'s Equity Buyback announced on April 8, 2022, has closed with 33,001,600 shares, representing 2.97% for CNY 289.98 million.	23-04-02	CI
Inner Mongolia JinYu Holdings Proposes Agenda Addition for JinYu Biological Technology's 2023 Employee Stock Ownership Plan	23-03-06	CI
Jinyu Bio-Technology’s Chairman, Vice Chairman to Become Actual Controllers After 800 Million Yuan Deal	23-02-08	MT
Jinyu Bio-technology Co., Ltd. announced that it expects to receive CNY 799.999997 million in funding from Inner Mongolia Jinyu Biological Holdings Co., Ltd., and other investors	23-02-06	CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.	23-01-04	CI
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.	22-10-09	CI
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.	22-07-04	CI
Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-21	CI
Jinyu Bio-technology Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares.	22-04-07	CI

Chart Jinyu Bio-technology Co., Ltd.

Duration

Period

More charts

JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.

Sector

Pharmaceuticals

Calendar

2024-04-25 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Jinyu Bio-technology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.11 CNY

Average target price

9.475 CNY

Spread / Average Target

+4.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
JINYU BIO-TECHNOLOGY CO., LTD.	-15.41%	1.37B
ZOETIS INC.	-22.30%	70.08B
BLUESTAR ADISSEO COMPANY	+18.88%	3.52B
VIRBAC	-3.62%	3.11B
VIMIAN GROUP AB	-2.87%	1.38B
VETOQUINOL SA	-4.30%	1.24B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-27.74%	1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD	-13.54%	1.13B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-2.99%	1.02B
SWEDENCARE AB	-10.35%	795M

Veterinary Drugs